Thus, in view of the well-established role of MT function and energy stores in maintaining cardiac function and structure, it is evident that sarpogrelate, like insulin, may improve cardiac performance in diabetic cardiomyopathy. This evidence concerns the gene INS and diabetic cardiomyopathy.